Ischemia-Modified Albumin in Acute Stroke
Halim Abboud(Saint Joseph University), Pierre Amarenco(Assistance Publique – Hôpitaux de Paris), Elena Meseguer(Université Paris Cité), Philippa C. Lavallée(Université Claude Bernard Lyon 1), Olivier Simon(Inserm), Mikaël Mazighi(Inserm), Jean‐Marc Olivot(Stanford University), Joëlle Bénessiano(Center for Clinical Research (United States)), Philippe Gabríel Steg(Mount Sinai Hospital), Monique Dehoux, Julien Labreuche(ASTER)
Cited by 166
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k